Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
NAS:ICUI's Cash to Debt is ranked higher than
96% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. NAS:ICUI: No Debt )
Ranked among companies with meaningful Cash to Debt only.
NAS:ICUI' s Cash to Debt Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Equity to Asset 0.94
NAS:ICUI's Equity to Asset is ranked higher than
96% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. NAS:ICUI: 0.94 )
Ranked among companies with meaningful Equity to Asset only.
NAS:ICUI' s Equity to Asset Range Over the Past 10 Years
Min: 0.85  Med: 0.92 Max: 0.96
Current: 0.94
0.85
0.96
Interest Coverage No Debt
NAS:ICUI's Interest Coverage is ranked higher than
96% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 35.09 vs. NAS:ICUI: No Debt )
Ranked among companies with meaningful Interest Coverage only.
NAS:ICUI' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
F-Score: 7
Z-Score: 39.20
M-Score: -0.75
WACC vs ROIC
5.89%
25.63%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 21.83
NAS:ICUI's Operating margin (%) is ranked higher than
88% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. NAS:ICUI: 21.83 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:ICUI' s Operating margin (%) Range Over the Past 10 Years
Min: 12.62  Med: 16.48 Max: 21.83
Current: 21.83
12.62
21.83
Net-margin (%) 15.18
NAS:ICUI's Net-margin (%) is ranked higher than
86% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. NAS:ICUI: 15.18 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:ICUI' s Net-margin (%) Range Over the Past 10 Years
Min: 8.52  Med: 12.5 Max: 15.18
Current: 15.18
8.52
15.18
ROE (%) 9.44
NAS:ICUI's ROE (%) is ranked higher than
64% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. NAS:ICUI: 9.44 )
Ranked among companies with meaningful ROE (%) only.
NAS:ICUI' s ROE (%) Range Over the Past 10 Years
Min: 5.41  Med: 10.47 Max: 15.02
Current: 9.44
5.41
15.02
ROA (%) 8.80
NAS:ICUI's ROA (%) is ranked higher than
78% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. NAS:ICUI: 8.80 )
Ranked among companies with meaningful ROA (%) only.
NAS:ICUI' s ROA (%) Range Over the Past 10 Years
Min: 5.06  Med: 9.36 Max: 13.27
Current: 8.8
5.06
13.27
ROC (Joel Greenblatt) (%) 48.30
NAS:ICUI's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. NAS:ICUI: 48.30 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:ICUI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 23.87  Med: 31.56 Max: 48.3
Current: 48.3
23.87
48.3
Revenue Growth (3Y)(%) -1.30
NAS:ICUI's Revenue Growth (3Y)(%) is ranked lower than
66% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. NAS:ICUI: -1.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:ICUI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -2.5  Med: 14.9 Max: 34.6
Current: -1.3
-2.5
34.6
EBITDA Growth (3Y)(%) -1.20
NAS:ICUI's EBITDA Growth (3Y)(%) is ranked lower than
69% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. NAS:ICUI: -1.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NAS:ICUI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -19.8  Med: 15.1 Max: 35
Current: -1.2
-19.8
35
EPS Growth (3Y)(%) -0.80
NAS:ICUI's EPS Growth (3Y)(%) is ranked lower than
65% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. NAS:ICUI: -0.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:ICUI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -32.2  Med: 12.7 Max: 66
Current: -0.8
-32.2
66
» NAS:ICUI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

ICUI Guru Trades in Q4 2015

Paul Tudor Jones 5,811 sh (+51.84%)
Jim Simons 812,800 sh (+6.58%)
Mario Gabelli 70,500 sh (-1.67%)
Joel Greenblatt 42,165 sh (-26.35%)
» More
Q1 2016

ICUI Guru Trades in Q1 2016

Ken Fisher 31,000 sh (New)
Paul Tudor Jones 7,031 sh (+20.99%)
Jim Simons 842,000 sh (+3.59%)
Mario Gabelli 70,500 sh (unchged)
Joel Greenblatt 40,595 sh (-3.72%)
» More
Q2 2016

ICUI Guru Trades in Q2 2016

Joel Greenblatt 41,529 sh (+2.30%)
Ken Fisher 31,000 sh (unchged)
Mario Gabelli 70,500 sh (unchged)
Jim Simons 793,100 sh (-5.81%)
Paul Tudor Jones 3,757 sh (-46.57%)
» More
Q3 2016

ICUI Guru Trades in Q3 2016

Joel Greenblatt 55,374 sh (+33.34%)
Paul Tudor Jones 4,251 sh (+13.15%)
Mario Gabelli 70,500 sh (unchged)
Ken Fisher 31,000 sh (unchged)
Jim Simons 739,000 sh (-6.82%)
» More
» Details

Insider Trades

Latest Guru Trades with ICUI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:OTCPK:ANSLY, NAS:PODD, NYSE:HAE, NYSE:HYH, NAS:NXTM, OTCPK:TOPCF, NYSE:CMN, NYSE:HRC, OTCPK:GNGBY, NYSE:GKOS, NAS:MMSI, NAS:LMNX, NAS:ATRI, NAS:NVCR, OTCPK:NNCSF, NAS:ATRC, NAS:ELGX, NAS:ANGO, NAS:OSUR, NAS:MLAB » details
Traded in other countries:IC7.Germany,
ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products include needlefree connectors, nanoclave, chemoclock, chemoclave, and among others.

ICU Medical Inc is a Delaware Corporation founded in 1984 and its initial public offering was in 1992. The Company is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. The Company's complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needle free infusion connectors, catheters and cardiac monitoring systems. Its products are categorized into three main product lines: Infusion Therapy, Critical Care and Oncology. I.V. therapy lines, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient's vein. The tube typically has several injection ports or Y-sites (conventionally, entry tubes covered by rubber caps) to which a secondary I.V. line can be connected to permit constant intravenous administration of medications, fluids and nutrients, and to allow instantaneous intravenous administration of emergency medication. Critical care products are used to monitor vital signs as well as specific physiological functions of key organ systems and Oncology: Oncology products are used to prepare and deliver hazardous medications such as those used in chemotherapy which, if released, can have harmful effects to the healthcare worker and environment. Manufacturing of its products involves injection molding of plastic and silicone parts, manual and automated assembly of the molded plastic parts, needles and other components, quality control inspection, packaging and sterilization. The Company currently sells all of its products to I.V. product manufacturers, independent distributors and direct sales to the end user. It competes with other manufacturers of closed system transfer devices for the safe handling of oncology drugs, notably Becton Dickinson, CareFusion and B Braun. The Company's products are subject to clearance by the United States Food and Drug Administration ("FDA") under a number of statutes including the Food Drug and Cosmetics Act ("FDC Act").

Ratios

vs
industry
vs
history
P/E(ttm) 43.12
ICUI's P/E(ttm) is ranked lower than
78% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.70 vs. ICUI: 43.12 )
Ranked among companies with meaningful P/E(ttm) only.
ICUI' s P/E(ttm) Range Over the Past 10 Years
Min: 13.76  Med: 23.35 Max: 52.73
Current: 43.12
13.76
52.73
Forward P/E 28.65
ICUI's Forward P/E is ranked lower than
78% of the 36 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.22 vs. ICUI: 28.65 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 43.12
ICUI's PE(NRI) is ranked lower than
80% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.99 vs. ICUI: 43.12 )
Ranked among companies with meaningful PE(NRI) only.
ICUI' s PE(NRI) Range Over the Past 10 Years
Min: 13.78  Med: 23.35 Max: 52.73
Current: 43.12
13.78
52.73
Price/Owner Earnings (ttm) 65.86
ICUI's Price/Owner Earnings (ttm) is ranked lower than
86% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. ICUI: 65.86 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ICUI' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 10.68  Med: 23.08 Max: 86.38
Current: 65.86
10.68
86.38
P/B 3.69
ICUI's P/B is ranked lower than
59% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.12 vs. ICUI: 3.69 )
Ranked among companies with meaningful P/B only.
ICUI' s P/B Range Over the Past 10 Years
Min: 1.4  Med: 2.18 Max: 3.82
Current: 3.69
1.4
3.82
P/S 6.48
ICUI's P/S is ranked lower than
79% of the 222 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.98 vs. ICUI: 6.48 )
Ranked among companies with meaningful P/S only.
ICUI' s P/S Range Over the Past 10 Years
Min: 1.73  Med: 2.9 Max: 6.76
Current: 6.48
1.73
6.76
PFCF 45.88
ICUI's PFCF is ranked lower than
77% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.87 vs. ICUI: 45.88 )
Ranked among companies with meaningful PFCF only.
ICUI' s PFCF Range Over the Past 10 Years
Min: 11.13  Med: 26.03 Max: 99.73
Current: 45.88
11.13
99.73
POCF 32.77
ICUI's POCF is ranked lower than
82% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.05 vs. ICUI: 32.77 )
Ranked among companies with meaningful POCF only.
ICUI' s POCF Range Over the Past 10 Years
Min: 9.21  Med: 14.94 Max: 34.46
Current: 32.77
9.21
34.46
EV-to-EBIT 24.34
ICUI's EV-to-EBIT is ranked lower than
62% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.14 vs. ICUI: 24.34 )
Ranked among companies with meaningful EV-to-EBIT only.
ICUI' s EV-to-EBIT Range Over the Past 10 Years
Min: 7  Med: 13 Max: 31.4
Current: 24.34
7
31.4
EV-to-EBITDA 19.74
ICUI's EV-to-EBITDA is ranked lower than
65% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.65 vs. ICUI: 19.74 )
Ranked among companies with meaningful EV-to-EBITDA only.
ICUI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.4  Med: 9 Max: 23
Current: 19.74
5.4
23
Shiller P/E 57.49
ICUI's Shiller P/E is ranked lower than
77% of the 47 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.92 vs. ICUI: 57.49 )
Ranked among companies with meaningful Shiller P/E only.
ICUI' s Shiller P/E Range Over the Past 10 Years
Min: 17.72  Med: 29.4 Max: 59.99
Current: 57.49
17.72
59.99
Current Ratio 15.47
ICUI's Current Ratio is ranked higher than
98% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. ICUI: 15.47 )
Ranked among companies with meaningful Current Ratio only.
ICUI' s Current Ratio Range Over the Past 10 Years
Min: 5.86  Med: 10.19 Max: 22.75
Current: 15.47
5.86
22.75
Quick Ratio 13.90
ICUI's Quick Ratio is ranked higher than
98% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. ICUI: 13.90 )
Ranked among companies with meaningful Quick Ratio only.
ICUI' s Quick Ratio Range Over the Past 10 Years
Min: 4.57  Med: 9.41 Max: 21.41
Current: 13.9
4.57
21.41
Days Inventory 97.69
ICUI's Days Inventory is ranked higher than
67% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 123.20 vs. ICUI: 97.69 )
Ranked among companies with meaningful Days Inventory only.
ICUI' s Days Inventory Range Over the Past 10 Years
Min: 47.92  Med: 84.94 Max: 101.19
Current: 97.69
47.92
101.19
Days Sales Outstanding 52.34
ICUI's Days Sales Outstanding is ranked higher than
67% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. ICUI: 52.34 )
Ranked among companies with meaningful Days Sales Outstanding only.
ICUI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.09  Med: 54.66 Max: 75.32
Current: 52.34
46.09
75.32
Days Payable 26.16
ICUI's Days Payable is ranked lower than
85% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.76 vs. ICUI: 26.16 )
Ranked among companies with meaningful Days Payable only.
ICUI' s Days Payable Range Over the Past 10 Years
Min: 24.54  Med: 26.17 Max: 54.81
Current: 26.16
24.54
54.81

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -3.60
ICUI's 3-Year Average Share Buyback Ratio is ranked lower than
53% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. ICUI: -3.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ICUI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.6  Med: -1.4 Max: 2
Current: -3.6
-4.6
2

Valuation & Return

vs
industry
vs
history
Price/Net Cash 7.10
ICUI's Price/Net Cash is ranked higher than
59% of the 61 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.94 vs. ICUI: 7.10 )
Ranked among companies with meaningful Price/Net Cash only.
ICUI' s Price/Net Cash Range Over the Past 10 Years
Min: 3.3  Med: 5.73 Max: 575
Current: 7.1
3.3
575
Price/Net Current Asset Value 5.09
ICUI's Price/Net Current Asset Value is ranked higher than
64% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.55 vs. ICUI: 5.09 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ICUI' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.72  Med: 3.42 Max: 5.31
Current: 5.09
1.72
5.31
Price/Tangible Book 3.80
ICUI's Price/Tangible Book is ranked higher than
54% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.38 vs. ICUI: 3.80 )
Ranked among companies with meaningful Price/Tangible Book only.
ICUI' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.31  Med: 2.41 Max: 4.06
Current: 3.8
1.31
4.06
Price/Projected FCF 2.57
ICUI's Price/Projected FCF is ranked lower than
57% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.04 vs. ICUI: 2.57 )
Ranked among companies with meaningful Price/Projected FCF only.
ICUI' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.79  Med: 1.56 Max: 2.68
Current: 2.57
0.79
2.68
Price/Median PS Value 2.24
ICUI's Price/Median PS Value is ranked lower than
87% of the 202 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.08 vs. ICUI: 2.24 )
Ranked among companies with meaningful Price/Median PS Value only.
ICUI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.6  Med: 1.12 Max: 2.45
Current: 2.24
0.6
2.45
Price/Graham Number 2.70
ICUI's Price/Graham Number is ranked lower than
54% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. ICUI: 2.70 )
Ranked among companies with meaningful Price/Graham Number only.
ICUI' s Price/Graham Number Range Over the Past 10 Years
Min: 0.91  Med: 1.58 Max: 3.7
Current: 2.7
0.91
3.7
Earnings Yield (Greenblatt) (%) 4.03
ICUI's Earnings Yield (Greenblatt) (%) is ranked higher than
63% of the 228 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. ICUI: 4.03 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ICUI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3.2  Med: 7.7 Max: 14.3
Current: 4.03
3.2
14.3
Forward Rate of Return (Yacktman) (%) 0.41
ICUI's Forward Rate of Return (Yacktman) (%) is ranked lower than
72% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.02 vs. ICUI: 0.41 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ICUI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2.1  Med: 12.7 Max: 27.3
Current: 0.41
-2.1
27.3

More Statistics

Revenue (TTM) (Mil) $374.1
EPS (TTM) $ 3.35
Beta0.47
Short Percentage of Float4.84%
52-Week Range $85.56 - 154.80
Shares Outstanding (Mil)16.33

Analyst Estimate

Dec16 Dec17 Dec18 Dec19
Revenue (Mil $) 378 854 1,497 1,557
EPS ($) 4.63 5.06 8.00 9.10
EPS w/o NRI ($) 4.63 5.06 8.00 9.10
EPS Growth Rate
(3Y to 5Y Estimate)
20.50%
Dividends Per Share ($)
» More Articles for NAS:ICUI

Headlines

Articles On GuruFocus.com
EW: Potential for Capital Appreciation Oct 03 2014 
Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH Mar 10 2014 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 2,388 Shares Nov 29 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 18,831 Shares Nov 24 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,406 Shares Nov 15 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 3,691 Shares Nov 09 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,500 Shares Nov 08 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 5,684 Shares Nov 05 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,000 Shares Nov 03 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 9,496 Shares Nov 02 2010 

More From Other Websites
ICU Medical Launches the All-New Diana™ Compounding Workflow System at the American Society of... Dec 01 2016
Pfizer Divests Hospira’s Infusion System Business to ICU Medical Nov 29 2016
ICU MEDICAL INC/DE Financials Nov 17 2016
ETFs with exposure to ICU Medical, Inc. : November 14, 2016 Nov 14 2016
ICU Medical, Inc. :ICUI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016 Nov 10 2016
Edited Transcript of ICUI earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016
ICU Medical beats 3Q profit forecasts Nov 09 2016
ICU Medical beats 3Q profit forecasts Nov 09 2016
ICU Medical, Inc. Announces Third Quarter 2016 Results Nov 09 2016
ICU MEDICAL INC/DE Files SEC form 8-K, Financial Statements and Exhibits Nov 09 2016
ICU Medical, Inc. Announces Third Quarter 2016 Results Nov 09 2016
Q3 2016 ICU Medical Inc Earnings Release - After Market Close Nov 09 2016
Medical Product Q3 Earnings on Nov 9: ICUI, EGRX & More Nov 08 2016
4 Medical Device Stocks on a Bull Run this Earnings Season Oct 26 2016
ICU Medical, Inc. Announces Time of Third Quarter 2016 Earnings Call Oct 17 2016
ICU Medical, Inc. Announces Time of Third Quarter 2016 Earnings Call Oct 17 2016
Pfizer’s Divestment of Hospira Infusion Systems Oct 14 2016
ICU MEDICAL INC/DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Oct 13 2016
ICU Medical (ICUI) Shares March Higher, Can It Continue? Oct 13 2016
Why ICU Medical (ICUI) Could Beat Earnings Estimates Again Oct 13 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)